2020
DOI: 10.1016/j.jmb.2019.12.029
|View full text |Cite
|
Sign up to set email alerts
|

Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
55
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 33 publications
(58 citation statements)
references
References 68 publications
3
55
0
Order By: Relevance
“…CSP is one of the leading malaria vaccine antigens [12]; the magnitude of antibody responses to either full length CSP [13] or its fragments has been identified as a potential biomarker of protection [14,15]. While the role of CSP-repeat-specific antibodies has been well documented [8,13,15,16], there are conflicting data on the role of C-terminus-specific antibodies [7,14,17] and their ability to contribute to protection against infection. The method described here enables high-throughput testing and permits profiling of large samples sets even when sample volumes are limited to determine the role of epitope specificity of CSP-specific antibodies.…”
Section: Discussionmentioning
confidence: 99%
“…CSP is one of the leading malaria vaccine antigens [12]; the magnitude of antibody responses to either full length CSP [13] or its fragments has been identified as a potential biomarker of protection [14,15]. While the role of CSP-repeat-specific antibodies has been well documented [8,13,15,16], there are conflicting data on the role of C-terminus-specific antibodies [7,14,17] and their ability to contribute to protection against infection. The method described here enables high-throughput testing and permits profiling of large samples sets even when sample volumes are limited to determine the role of epitope specificity of CSP-specific antibodies.…”
Section: Discussionmentioning
confidence: 99%
“…The antibodies in this study were derived from protected volunteers in a phase 2a trial of RTS,S/AS01 seven days after the third fractional dose, as previously reported (27)(28)(29). Antibodies were selected from among expanded sequence families with a focus on prevalent IGHV families.…”
Section: Many Anti-nanp Antibodies Examined In This Study Show Potentmentioning
confidence: 99%
“…However, recent evidence suggests that anti-junction mAbs can also cross-react with the NANP repeats, and their protective capacity can be correlated with their binding promiscuity to NANP (24,25). Epitopes of anti-NANP antibodies typically contain 2-3 NPNA structural motifs, which can adopt local conformations of a type I β-turn and an Asn pseudo 310 turn (22,23,(26)(27)(28)(29)(30). Anti-NANP antibodies often utilize a germline-encoded Trp residue to interact with the Pro or Asn in the NPNA turns (29).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations